TSDOF (Tessenderlo Group NV) Total Liabilities : $1,033 Mil (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Tessenderlo Group NV Total Liabilities?

Tessenderlo Group NV's Total Liabilities for the quarter that ended in Jun. 2024 was $1,033 Mil.

Tessenderlo Group NV's quarterly Total Liabilities declined from Jun. 2023 ($1,207.04 Mil) to Dec. 2023 ($1,053.33 Mil) and declined from Dec. 2023 ($1,053.33 Mil) to Jun. 2024 ($1,033.05 Mil).

Tessenderlo Group NV's annual Total Liabilities declined from Dec. 2021 ($1,215.48 Mil) to Dec. 2022 ($950.85 Mil) but then increased from Dec. 2022 ($950.85 Mil) to Dec. 2023 ($1,053.33 Mil).

Tessenderlo Group NV Total Liabilities Historical Data

The historical data trend for Tessenderlo Group NV's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tessenderlo Group NV Total Liabilities Chart

Tessenderlo Group NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,208.56

1,292.34

1,215.48

950.85

1,053.33

Tessenderlo Group NV Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Liabilities	Get a 7-Day Free Trial															1,121.46	950.85	1,207.04	1,053.33	1,033.05

Tessenderlo Group NV Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Tessenderlo Group NV's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	534.569	+	(191.167	+	278.517
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	49.073)
	=	1,053

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3178.517	-	2125.191
	=	1,053

Tessenderlo Group NV's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	566.523	+	(165.339	+	259.096
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	42.088)
	=	1,033

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	3132.723	-	2099.677
	=	1,033

Tessenderlo Group NV Total Liabilities Related Terms

Thank you for viewing the detailed overview of Tessenderlo Group NV's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Tessenderlo Group NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Tessenderlo Group NV (OTCPK:TSDOF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

0KCP:UK TEZ:Germany TESB:Belgium

Address

Troonstraat 130 Rue du Trone, Brussels, BEL, 1050

Website

https://www.tessenderlo.com

Tessenderlo Group NV is a diversified international agricultural and industrial company. The firm produces and sells products across four segments: Agro, Industrial Solutions, Bio-Valorization, and T-Power. The majority of its revenue comes from the Agro segment, which produces and sells liquid crop fertilizers, potassium sulfate, and crop protection products to the agriculture industry. The Industrial Solutions segment produces and sells plastic pipe systems, water treatment chemicals, and other industrial products. The Bio-Valorization segment processes animal by-products into gelatins for customers in the food, pharmaceutical, health, and nutrition industries. The company's revenue is generated in the United States.